VRTX
Vertex Pharmaceuticals Incorporated
$408.02
+$0.23(+0.06%)
59
Overall
60
Value
50
Tech
68
Quality
Market Cap
$104.55B
Volume
486.68K
52W Range
$362.50 - $519.88
Target Price
$491.56
Key Metrics Overview
| Market Cap | $104.55B | P/E Ratio | 25.76 |
| 52W High | $519.88 | 52W Low | $362.50 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -30.6% | 52W Position | 28.9% |
| Overall Score | 59 | Value Score | 60 |
| Quality Score | 68 | Technical Score | 50 |
Growth Analysis
| EPS Current Est | $15.84 | EPS Next Est | $17.39 |
| EPS Growth Est | +9.8% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $408.02 | +0.1% | 486.68K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW